272 related articles for article (PubMed ID: 9184386)
1. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
[TBL] [Abstract][Full Text] [Related]
2. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response.
O'Donnell J; Mumford AD; Manning RA; Laffan M
Thromb Haemost; 2000 Jan; 83(1):10-3. PubMed ID: 10669146
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism.
O'Donnell J; Laffan M
Clin Lab; 2001; 47(1-2):1-6. PubMed ID: 11214218
[TBL] [Abstract][Full Text] [Related]
4. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
Kamphuisen PW; Eikenboom JC; Vos HL; Pablo R; Sturk A; Bertina RM; Rosendaal FR
Thromb Haemost; 1999 May; 81(5):680-3. PubMed ID: 10365736
[TBL] [Abstract][Full Text] [Related]
6. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
[TBL] [Abstract][Full Text] [Related]
7. [A new thrombophilia risk factor: the increase of plasma factor VIII].
Hernández-Jerónimo J; Pérez-Campos E; Matadamas C; Majluf-Cruz A
Rev Invest Clin; 2003; 55(4):448-57. PubMed ID: 14635611
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.
Huser B; Lämmle B; Landmann J; Tran TH; Oberholzer M; Marbet GA; Thiel G; Mihatsch MJ; Duckert F
Clin Nephrol; 1990 Nov; 34(5):214-22. PubMed ID: 2125251
[TBL] [Abstract][Full Text] [Related]
9. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
[TBL] [Abstract][Full Text] [Related]
10. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
11. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
12. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
Lippi G; Franchini M; Targher G; Poli G; Guidi GC
Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
[TBL] [Abstract][Full Text] [Related]
13. Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.
Martinelli N; Girelli D; Ferraresi P; Olivieri O; Lunghi B; Manzato F; Corrocher R; Bernardi F
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):125-9. PubMed ID: 17287628
[TBL] [Abstract][Full Text] [Related]
14. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
Kraaijenhagen RA; in't Anker PS; Koopman MM; Reitsma PH; Prins MH; van den Ende A; Büller HR
Thromb Haemost; 2000 Jan; 83(1):5-9. PubMed ID: 10669145
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
Catto AJ; Carter AM; Barrett JH; Bamford J; Rice PJ; Grant PJ
Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
[TBL] [Abstract][Full Text] [Related]
17. The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis.
Tichelaar V; Mulder A; Kluin-Nelemans H; Meijer K
Thromb Res; 2012 Feb; 129(2):183-6. PubMed ID: 21992898
[TBL] [Abstract][Full Text] [Related]
18. Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?
Lwaleed BA; Greenfield R; Royle E; Birch B; Cooper AJ
Int J Androl; 2005 Feb; 28(1):31-8. PubMed ID: 15679619
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Probst K; Fijnheer R; Rothova A
Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
[TBL] [Abstract][Full Text] [Related]
20. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
Nossent AY; Eikenboom JC; Vos HL; Bakker E; Tanis BC; Doggen CJ; Bertina RM; Rosendaal FR
Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
